Cortina Asset Management’s Catheter Precision VTAK Stock Holding History

Cortina Asset Management’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$3.15M	–	240
2018 Q3	$3.15M	Buy	+1	New	+$4.54M	0.15%	213

Other funds holding VTAK

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Cortina Asset Management's VTAK Position: Q4 2018 in Review

Cortina Asset Management sold out of Catheter Precision (VTAK) in Q4 2018, closing a stake of 1 share — an estimated $3.15M sold.

Cortina Asset Management first reported a position in VTAK in Q3 2018 and held it in 1 quarter. The position peaked at $3.15M in Q3 2018. 10 funds tracked by Wall St. Rank hold VTAK as of Q4 2018.

Cortina Asset Management reported no remaining Catheter Precision position as of Q4 2018 after selling out during the quarter.
Cortina Asset Management sold 1 Catheter Precision share in Q4 2018, an estimated $3.15M.
Cortina Asset Management first reported a position in Catheter Precision in Q3 2018 and held it in 1 quarter.
Cortina Asset Management's Catheter Precision position peaked at $3.15M in Q3 2018.
10 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2018.

Based on Cortina Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.